NC-B8, our lead to protect the BRAIN
Brain penetrant, humanized, IgG4 monoclonal antibody
Intraveinous route of administration - monthly administration
Priority indication: Amyotrophic Lateral Sclerosis (ALS)
To be broaden to Parkinson's, Alzheimer's, Multiple Sclerosis
Achieved:
- Strong preclinical data-package of Efficacy in two species (mice and dogs)
- Good safety profile
- Companion biomarkers
- First regulatory steps
NC-P7, our lead to protect the HEART and the KIDNEY
Subcutaneous route of administration - weekly administration
Achieved:
- Strong preclinical data-package of Efficacy in two species (mice and dogs)
- Good safety profile
- Companion biomarkers
Version imprimable 